291 related articles for article (PubMed ID: 6114836)
1. Metabolism of 3-phenoxybenzoic acid and the enterohepatorenal disposition of its metabolites in the rat.
Huckle KR; Chipman JK; Hutson DH; Millburn P
Drug Metab Dispos; 1981; 9(4):360-8. PubMed ID: 6114836
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the metabolism of 3-phenoxybenzoic acid.
Huckle KR; Hutson DH; Millburn P
Drug Metab Dispos; 1981; 9(4):352-9. PubMed ID: 6114835
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.
Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP
Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
7. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways.
Dalvie DK; Khosla NB; Navetta KA; Brighty KE
Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858
[TBL] [Abstract][Full Text] [Related]
9. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of [3H]-l-menthol in the rat.
Yamaguchi T; Caldwell J; Farmer PB
Drug Metab Dispos; 1994; 22(4):616-24. PubMed ID: 7956738
[TBL] [Abstract][Full Text] [Related]
12. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of alpha-phosphonosulfonate squalene synthase inhibitors. I. Disposition of a farnesylethyl alpha-phosphonosulfonate and ester prodrugs in rats.
Lan SJ; Hsieh DC; Hillyer JW; Fancher RM; Rinehart KJ; Warrack BM; White RE
Drug Metab Dispos; 1998 Oct; 26(10):993-1000. PubMed ID: 9763405
[TBL] [Abstract][Full Text] [Related]
14. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
15. Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat. Hydrolysis of glucuronic acid conjugates in the gut lumen.
Parker RJ; Hirom PC; Millburn P
Xenobiotica; 1980 Sep; 10(9):689-703. PubMed ID: 7445530
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics of 1,2-diethylbenzene in male Sprague-Dawley rats-part 1: excretion and metabolism of [(14)C]1,2-diethylbenzene.
Payan JP; Beydon D; Cossec B; Ensminger A; Fabry JP; Ferrari E
Drug Metab Dispos; 1999 Dec; 27(12):1470-8. PubMed ID: 10570029
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution and biliary excretion of prostacyclin metabolites in the rat.
Taylor BM; Sun FF
J Pharmacol Exp Ther; 1980 Jul; 214(1):24-30. PubMed ID: 6993658
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
[TBL] [Abstract][Full Text] [Related]
19. Identification of ractopamine hydrochloride metabolites excreted in rat bile.
Smith DJ; Giddings JM; Feil VJ; Paulson GD
Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724
[TBL] [Abstract][Full Text] [Related]
20. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
Dickinson RG; Kluck RM; Eadie MJ; Hooper WD
J Pharmacol Exp Ther; 1985 Apr; 233(1):214-21. PubMed ID: 3920383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
